CGEM logo

Cullinan Oncology (CGEM) EBIT

Annual EBIT

-$190.65 M
-$58.51 M-44.28%

December 31, 2023

Summary

Performance

1-Year Change

-44.28%

3-Year Change

-215.98%

5-Year Change

-1207.07%

15-Year Change

-81443.63%

CGEM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.81%
CGEM annual earnings before interest & taxes is higher than 9.81% of companies in Healthcare sector

High & Low

All-time High

-$36.50 K

3-Year Low

-$190.65 M
CGEM annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CGEM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
CGEM next annual earnings announcement is scheduled for Mar 14, 2025

OtherCGEMprofitabilitymetrics:

Annual Revenue

-
CGEM annual revenue value is unknown

Annual Net Income

-$153.16 M
CGEM annual net profit is -$153.16 million

Annual EBITDA

-$190.34 M
CGEM annual EBITDA is -$190.34 million

Annual EPS

-$3.69
CGEM annual earnings per share is -$3.69

Quarterly EBIT

-$48.85 M
+$1.17 M+2.34%

September 30, 2024

Summary

Performance

3-Month Change

+2.34%

1-Year Change

+2.34%

3-Year Change

-165.88%

5-Year Change

-14520.01%

CGEM Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

10%
CGEM quarterly earnings before interest & taxes is higher than 10% of companies in Healthcare sector

High & Low

All-time High

$1.37 M
CGEM quarterly earnings before interest & taxes is currently -3660.86% below its historical high of $1.37 million

3-Year Low

-$62.76 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CGEM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CGEM next earnings announcement is scheduled for Mar 14, 2025

OtherCGEMprofitabilitymetrics:

Quarterly Revenue

-
CGEM quarterly revenue value is unknown

Quarterly Net Income

-$40.56 M
CGEM quarterly net profit is -$40.56 million

Quarterly EBITDA

-$48.78 M
CGEM quarterly EBITDA is -$48.78 million

Quarterly EPS

-$0.69
CGEM quarterly earnings per share is -$0.69

TTM EBIT

-$187.36 M
-$4.05 M-2.21%

September 30, 2024

Summary

Performance

3-Month Change

-2.21%

1-Year Change

-2.21%

3-Year Change

-198.43%

5-Year Change

-5224.13%

CGEM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

10.59%
CGEM TTM earnings before interest & taxes is higher than 10.59% of companies in Healthcare sector

High & Low

All-time High

$2.75 M
CGEM TTM earnings before interest & taxes is currently -6922.37% below its historical high of $2.75 million

3-Year Low

-$190.65 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CGEM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CGEM next earnings announcement is scheduled for Mar 14, 2025

OtherCGEMprofitabilitymetrics:

TTM Revenue

-
CGEM TTM revenue value is unknown

TTM Net Income

-$143.54 M
CGEM TTM net profit is -$143.54 million

TTM EBITDA

-$187.05 M
CGEM TTM EBITDA is -$187.05 million

TTM EPS

-$2.84
CGEM TTM earnings per share is -$2.84

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$190.65 M
CGEM annual earnings before interest & taxes is -$190.65 million

Annual Revenue

-
CGEM annual revenue value is unknown

Annual Cost Of Goods Sold

-
CGEM annual cost of goods sold value is unknown

Annual Operating Expenses

$190.65 M
CGEM annual total operating expenses is $190.65 million

CGEM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-44.3%+2.3%-2.2%
3 y3 years-216.0%-165.9%-198.4%
5 y5 years-1207.1%-10000.0%-5224.1%

CGEM EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-180.6%at low-64.1%+22.1%-175.7%+1.7%
5 y5-year-756.1%at low-3660.9%+22.1%-5224.1%+1.7%
alltimeall time<-9999.0%at low-3660.9%+22.1%-6922.4%+1.7%

Cullinan Oncology EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$48.85 M(-2.3%)
-$187.36 M(+2.2%)
Jun 2024
-
-$50.03 M(+16.4%)
-$183.30 M(+7.3%)
Mar 2024
-
-$42.99 M(-5.5%)
-$170.88 M(-10.4%)
Dec 2023
-$190.65 M(+44.3%)
-$45.48 M(+1.5%)
-$190.65 M(+7.2%)
Sep 2023
-
-$44.80 M(+19.1%)
-$177.77 M(+9.2%)
Jun 2023
-
-$37.60 M(-40.1%)
-$162.74 M(+0.3%)
Mar 2023
-
-$62.76 M(+92.5%)
-$162.24 M(+22.8%)
Dec 2022
-$132.14 M(+94.5%)
-$32.61 M(+9.5%)
-$132.14 M(-1.3%)
Sep 2022
-
-$29.77 M(-19.8%)
-$133.88 M(+9.3%)
Jun 2022
-
-$37.11 M(+13.6%)
-$122.48 M(+20.1%)
Mar 2022
-
-$32.66 M(-4.9%)
-$101.98 M(+50.1%)
Dec 2021
-$67.95 M(+12.6%)
-$34.35 M(+86.9%)
-$67.95 M(+8.2%)
Sep 2021
-
-$18.38 M(+10.7%)
-$62.78 M(+12.3%)
Jun 2021
-
-$16.60 M(-1310.2%)
-$55.90 M(+4.6%)
Mar 2021
-
$1.37 M(-104.7%)
-$53.42 M(-11.5%)
Dec 2020
-$60.34 M(+170.9%)
-$29.17 M(+153.7%)
-$60.34 M(+66.9%)
Sep 2020
-
-$11.50 M(-18.6%)
-$36.14 M(+48.7%)
Jun 2020
-
-$14.12 M(+154.9%)
-$24.30 M(+139.5%)
Mar 2020
-
-$5.54 M(+11.3%)
-$10.15 M(+188.3%)
Dec 2019
-$22.27 M
-$4.98 M(-1569.6%)
-$3.52 M(-288.3%)
DateAnnualQuarterlyTTM
Sep 2019
-
$338.80 K(+862.5%)
$1.87 M(+12.0%)
Jun 2019
-
$35.20 K(-96.8%)
$1.67 M(-39.2%)
Mar 2019
-
$1.09 M(+165.5%)
$2.75 M(+16.8%)
Dec 2018
-$14.59 M(+6138.7%)
-
-
Dec 2018
-
$409.10 K(+194.7%)
$2.35 M(+174.3%)
Sep 2018
-
$138.80 K(-87.5%)
$857.30 K(-34.9%)
Jun 2018
-
$1.11 M(+60.9%)
$1.32 M(+220.0%)
Mar 2018
-
$691.10 K(-163.7%)
$411.80 K(-247.4%)
Dec 2017
-
-$1.08 M(-281.1%)
-$279.30 K(-134.7%)
Sep 2017
-
$599.10 K(+190.1%)
$805.60 K(+290.1%)
Jun 2017
-
$206.50 K
$206.50 K
Dec 2016
-$233.80 K(+225.6%)
-
-
Dec 2015
-$71.80 K(-38.2%)
-
-
Dec 2014
-$116.20 K(-82.8%)
-
-
Dec 2013
-$676.80 K(+285.6%)
-
-
Dec 2012
-$175.50 K(+9.2%)
-
-
Dec 2011
-$160.70 K(-80.1%)
-
-
Dec 2010
-$806.50 K(+106.5%)
-
-
Dec 2009
-$390.50 K(+969.9%)
-
-
Dec 2008
-$36.50 K
-
-

FAQ

  • What is Cullinan Oncology annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Cullinan Oncology?
  • What is Cullinan Oncology annual EBIT year-on-year change?
  • What is Cullinan Oncology quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Cullinan Oncology?
  • What is Cullinan Oncology quarterly EBIT year-on-year change?
  • What is Cullinan Oncology TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Cullinan Oncology?
  • What is Cullinan Oncology TTM EBIT year-on-year change?

What is Cullinan Oncology annual earnings before interest & taxes?

The current annual EBIT of CGEM is -$190.65 M

What is the all time high annual EBIT for Cullinan Oncology?

Cullinan Oncology all-time high annual earnings before interest & taxes is -$36.50 K

What is Cullinan Oncology annual EBIT year-on-year change?

Over the past year, CGEM annual earnings before interest & taxes has changed by -$58.51 M (-44.28%)

What is Cullinan Oncology quarterly earnings before interest & taxes?

The current quarterly EBIT of CGEM is -$48.85 M

What is the all time high quarterly EBIT for Cullinan Oncology?

Cullinan Oncology all-time high quarterly earnings before interest & taxes is $1.37 M

What is Cullinan Oncology quarterly EBIT year-on-year change?

Over the past year, CGEM quarterly earnings before interest & taxes has changed by +$1.17 M (+2.34%)

What is Cullinan Oncology TTM earnings before interest & taxes?

The current TTM EBIT of CGEM is -$187.36 M

What is the all time high TTM EBIT for Cullinan Oncology?

Cullinan Oncology all-time high TTM earnings before interest & taxes is $2.75 M

What is Cullinan Oncology TTM EBIT year-on-year change?

Over the past year, CGEM TTM earnings before interest & taxes has changed by -$4.05 M (-2.21%)